Issue 17: September/October


Launch of the New Stay Connected Website

StayConnected Website Redesign

GEDSA's Stay Connected website has been available as an information source for over a year providing a unified message from our member enteral supplier companies.  Recently we have refreshed the look of our Stay Connected site making it organized for visitors to easily reach the information they are looking for.  Other changes include a syringe tab which illustrates GEDSA's recommended delivery protocols and relevant information about new ENFit™ tip syringes.

Visit the New Stay Connected Site

  Did you know?  

Translated Resources

We have taken our most valuable resources and translated them into 7 languages.  You can find items such as FAQ sheets, brochures, and videos translated into: Dutch, French, German, Italian, Portuguese, and Spanish.

Find a Translated Resource

  Do you have?  

Pharmacy Checklist

Enterally delivered medication will use an ENFit tip syringe.  Share our pharmacy checklist and other Stay Connected tools and information with the pharmacy director, satellite pharmacy managers, clinical pharmacists, and pharmacy technicians to help smooth the transition to new ENFit connectors.

View Transition Checklist for Pharmacists

  Have you met?  

Deborah Pasko, Pharm.D., MHA
Director of Medication Safety and Quality
Center on Medication Safety and Quality
American Society of Health System Pharmacists (ASHP)

Before coming to ASHP in October 2014, Dr. Pasko was an Administrative Clinical Specialist and Sr. Project Manager at the University of Michigan CS Mott Children's and Women's Hospital.  Her work there in safety (patient and medication related) in addition to chairing the Pediatric Medication Safety Committee for 8 years led her to her current role as Director of Medication Safety and Quality at ASHP.  Deborah has vast experience in both clinical and administrative arenas of health systems.  Recently she has been co-leading an effort with ISMP's President, Mike Cohen, on helping health organizations transition to using the ENFit syringe designed to meet the new ISO standards  for enterally delivered medication.


" ASHP has been very pleased with the collaborative efforts between industry, governmental agencies, national safety organizations, health organizations and patients/caregivers.  In my new role it is very exciting for me to experience such an omnibus effort to do the right thing for the patient.  The new enteral tubing and syringe will enhance patient safety and ensure accurate medication delivery"

-Dr. Deborah Pasko

  Have you told?  

Nursing, Nutrition and Dietetics Leads

Share this email with your nurse managers, nursing staff, and dietitians to help them Stay Connected.

Forward this Email


Where to find us

October 19

American Society for Healthcare Risk Management (ASHRM) 2015 Conference; Indianapolis, IN

October 20

Children's Hospital Association Improving Performance Conference; Baltimore, MD

November 9-11

MedAssets Business and Technology Forum; Dallas, TX

December 7-10

American Society of Health System Pharmacists (ASHP) Clinical Midyear Conference; New Orleans, LA


The Stay Connected initiative is organized by the Global Enteral Device Supplier Association (GEDSA) in partnership with leading regulators, associations and other supporting organizations.


If this email was forwarded to you and you would like to sign up to Stay Connected, click here.

© 2015 GEDSA, all rights reserved

692 N. High St. Suite 207
Columbus, OH 43215 USA

Unsubscribe | Privacy

GEDSA is a 501(c)(6) federal tax exempt Non-Profit Trade Association incorporated in the State of Ohio, USA. GEDSA’s mission is to promote initiatives surrounding safe and optimal delivery of enteral feeding and connectivity. It is GEDSA’s policy and the responsibility of every GEDSA member to comply in all respects with federal, state and international antitrust laws. Any discussion is strictly prohibited for the purpose of raising, lowering, or stabilizing prices; regulating production; allocating markets; encouraging boycotts; fostering unfair trade practices; or assisting monopolization at any GEDSA function. Any questions regarding the meaning or applicability of this policy, as well as any concerns regarding activities or discussions at GEDSA functions, should be promptly brought to the attention of GEDSA’s executive director, officers, and/or legal counsel.

All material provided in this email is intended for informational purposes only and should not be used to replace regulatory or company-specific documents, nor should it replace the advice of a qualified professional. This information is based on the draft ISO 80369 standard; does not imply or suggest any regulatory clearance of any specific product and may not be predictive of clinical outcomes. Images provided do not imply endorsement of any specific product. All products and product designs are the responsibility of each specific legal manufacturer, distributor or supplier. Products with these design features may be pending regulatory clearance or may not be available in a specific geography. Consult your supplier representative for product-specific availability, indications, contraindications, precautions, and warnings.


This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
GEDSA · 692 N. High St. Suite 304 · Columbus, OH 43215 · USA